Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families

Cancer Genetics and Cytogenetics

Volumn 165, Issue 2, 2006, Pages 91-97

  Lynch, Henry T ^a   Snyder, Carrie ^a   Lynch, Jane F ^a   Karatoprakli, Peggy ^a   Trowonou, Abdon ^a   Metcalfe, Kelly ^b   Narod, Steven A ^b   Gong, Gordon ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER FAMILY; CANCER PATIENT; CANCER PREVENTION; CANCER SCREENING; CANCER SURGERY; CARCINOGENESIS; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC PROCEDURES; HEALTH INSURANCE; HEALTH STATUS; HETEROZYGOTE; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MUTATIONAL ANALYSIS; OVARIECTOMY; OVARY CARCINOMA; PATIENT ATTITUDE; PRIORITY JOURNAL; PSYCHOLOGY; QUESTIONNAIRE; SEX DIFFERENCE; SIBLING; STATISTICAL SIGNIFICANCE; TRANSVAGINAL ECHOGRAPHY;

BREAST NEOPLASMS; DISCLOSURE; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC SCREENING; HUMANS; MAMMOGRAPHY; MUTATION; OVARIAN NEOPLASMS; PATIENT COMPLIANCE; ULTRASONOGRAPHY;

EID: 33644779724     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.07.011     Document Type: Article

References (32)

1. V. Bonadona, P. Saltel, F. Desseigne, H. Mignotte, J.C. Saurin, Q. Wang, O. Sinilnikova, S. Giraud, G. Freyer, H. Plauchu, A. Puisieux, and C. Lasset Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result Cancer Epidemiol Biomarkers Prev 11 2002 97 104
2. A.E. Guttmacher, F.S. Collins, and R.H. Carmona The family history: more important than ever N Engl J Med 351 2004 2333 2336
3. D. Cella, C. Hughes, A. Peterman, C.-H. Chang, B.N. Peshkin, M.D. Schwartz, L. Wenzel, A. Lemke, A.C. Marcus, and C. Lerman A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire Health Psychol 21 2002 564 572
4. H.T. Lynch, and A.J. Krush Carcinoma of the breast and ovary in three families Surg Gynecol Obstet 133 1971 644 648
5. H.T. Lynch, A.J. Krush, H.M. Lemon, A.R. Kaplan, P.T. Condit, and R.H. Bottomley Tumor variation in families with breast cancer JAMA 222 1972 1631 1635
6. H.T. Lynch, G.S. Schuelke, I.C. Wells, S.-C. Cheng, W.J. Kimberling, K.A. Biscone, J.F. Lynch, and B.S. Danes Hereditary ovarian carcinoma: biomarker studies Cancer 55 1985 410 415
7. S.C. Rubin, I. Benjamin, K. Behbakht, H. Takahashi, M.A. Morgan, V.A. LiVolsi, A. Berchuck, M.G. Muto, J.E. Garber, B.L. Weber, H.T. Lynch, and J. Boyd Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1 N Engl J Med 335 1996 1413 1416
8. M.C. King, R.C. Go, R.C. Elston, H.T. Lynch, and N.L. Petrakis Allele increasing susceptibility to human breast cancer may be linked to the glutamate-pyruvate transaminase locus Science 208 1980 406 408
9. M.C. King, R.C. Go, H.T. Lynch, R.C. Elston, P.I. Terasaki, N.L. Petrakis, G.C. Rodgers, D. Lattanzio, and J. Bailey-Wilson Genetic epidemiology of breast cancer and associated cancers in high-risk families. II. Linkage analysis J Natl Cancer Inst 71 1983 463 467
10. J.M. Hall, M.K. Lee, B. Newman, J.E. Morrow, L.A. Anderson, B. Huey, and M.C. King Linkage of early-onset breast cancer to chromosome 17q21 Science 250 1990 1684 1689
11. B. Rosner Fundamentals of biostatistics 2000 Duxbury Thomson Learning Pacific Grove, CA
12. W.J. Conover Practical nonparametric statistics 1999 John Wiley New York
13. N.J. Camp, and J.M. Farnham Correcting for multiple analyses in genomewide linkage studies Ann Hum Genet 65 2001 577 582
14. J.M. Linacre WINSTEPS [Computer program] 2004 Winsteps Chicago
15. H.T. Lynch, and A. de la Chapelle Hereditary colorectal cancer N Engl J Med 348 2003 919 932
16. T.R. Rebbeck, H.T. Lynch, S.L. Neuhausen, S.A. Narod, L. van't Veer, J.E. Garber, G. Evans, C. Isaacs, M.B. Daly, E. Matloff, O.I. Olopade, and B.L. Weber Prevention and Observation of Surgical End Points Study Group. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 2002 1616 1622
17. L.C. Hartmann, T.A. Sellers, D.J. Schaid, T.S. Frank, C.L. Soderberg, D.L. Sitta, M.H. Frost, C.S. Grant, J.H. Donohue, J.E. Woods, S.K. McDonnell, C. Walsh Vockley, A. Deffenbaugh, F.J. Couch, and R.B. Jenkins Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers J Natl Cancer Inst 93 2001 1633 1637
18. M. Broadstock, S. Michie, and T. Marteau Psychological consequences of predictive genetic testing: a systematic review Eur J Hum Genet 8 2000 731 738
19. L.N. Lodder, P.G. Frets, R.W. Trijsburg, E.J. Meijers-Heijboer, J.G. Klijn, C. Seynaeve, A.N. van Geel, M.M. Tilanus, C.C. Bartels, L.C. Verhoog, C.T. Brekelmans, C.W. Burger, and M.F. Niermeijer One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and the decisions on risk management (surveillance or prophylactic surgery) Breast Cancer Res Treat 73 2002 97 112
20. M.L. di Pietro, A. Giuli, and A.G. Spagnolo Ethical implications of predictive DNA testing for hereditary breast cancer Ann Oncol 15 Suppl 1 2004 i65 i70
21. J.C. Coyne, L. Kruus, M. Racioppo, K.A. Calzone, and K. Armstrong What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer? Am J Med Genet A 116 2003 222 228
22. H.T. Lynch, S.J. Lemon, C. Durham, S.T. Tinley, C. Connolly, J. Lynch, J. Surdam, E. Orinion, S. Slominski-Caster, P. Watson, C. Lerman, P. Tonin, O. Serova, G. Lenoir, and S. Narod A descriptive study of BRCA1 testing and reactions to disclosure of test results Cancer 79 1997 2219 2228
23. M. DiCastro, M. Frydman, I. Friedman, R. Shiri-Sverdlov, M.Z. Papa, B. Goldman, and E. Friedman Genetic counseling in hereditary breast/ovarian cancer in Israel: Psychosocial impact and retention of genetic information Am J Med Genet 111 2002 147 151
24. L. Lodder, P.G. Frets, R.W. Trijsburg, E.J. Meijers-Heijboer, J.G.M. Klijn, H.J. Duivenvoorden, A. Tibben, A. Wagner, A.C. van der Meer, A.M.W. van den Ouweland, and M.F. Nieermeijer Psychological impact of receiving a BRCA1/BRCA2 test result Am J Med Genet 98 2001 15 24
25. B. Meiser, M.A. Gleeson, and K.M. Tucker Psychological impact of genetic testing for adult-onset disorders: an update for clinicians Med J Aust 172 2000 126 129
26. C. Lerman, C. Hughes, S.J. Lemon, D. Main, C. Snyder, C. Durham, S. Narod, and H.T. Lynch What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing J Clin Oncol 16 1998 1650 1654
27. M.D. Schwartz, B.N. Peshkin, C. Hughes, D. Main, C. Isaacs, and C. Lerman Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample J Clin Oncol 20 2002 514 520
28. S.E. Plon, L.E. Peterson, L.C. Friedman, and C.S. Richards Mammography behavior after receiving a negative BRCA1 mutation test result in the Ashkenazim: a community-based study Genet Med 2 2000 307 311
29. J.C. Coyne, N.R. Benazon, C.G. Gaba, K. Calzone, and B.L. Weber Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families J Consult Clin Psychol 68 2000 864 874
30. C. Lerman, M. Daly, A. Masny, and A. Balshem Attitudes about genetic testing for breast-ovarian cancer susceptibility J Clin Oncol 12 1994 843 850
31. C. Lerman, S. Narod, K. Schulman, C. Hughes, A. Gomez-Caminero, G. Bonney, K. Gold, B. Trock, D. Main, J. Lynch, C. Fulmore, C. Snyder, S.J. Lemon, T. Conway, P. Tonin, G. Lenoir, and H. Lynch BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision-making and outcomes JAMA 275 1996 1885 1892
32. R.T. Croyle, K.R. Smith, J.R. Botkin, B. Baty, and J. Nash Psychological responses to BRCA1 mutation testing: preliminary findings Health Psychol 16 1997 63 72